7.98
-0.01(-0.13%)
Currency In USD
| Previous Close | 7.99 |
| Open | 7.97 |
| Day High | 8.19 |
| Day Low | 7.95 |
| 52-Week High | 12.65 |
| 52-Week Low | 5.51 |
| Volume | 3.2M |
| Average Volume | 4.61M |
| Market Cap | 2.46B |
| PE | -66.5 |
| EPS | -0.12 |
| Moving Average 50 Days | 6.7 |
| Moving Average 200 Days | 7.88 |
| Change | -0.01 |
If you invested $1000 in Amicus Therapeutics, Inc. (FOLD) 10 years ago, it would be worth $459.94 as of September 08, 2025 at a share price of $7.98. Whereas If you bought $1000 worth of Amicus Therapeutics, Inc. (FOLD) shares 5 years ago, it would be worth $591.11 as of September 08, 2025 at a share price of $7.98.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
GlobeNewswire Inc.
8 hours ago
Long-Term Data Adds to the Growing Body of Evidence Supporting the Compelling Clinical Profile of Pombiliti® + Opfolda®PRINCETON, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the presentation of new 4
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
GlobeNewswire Inc.
Aug 29, 2025 11:00 AM GMT
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September. Cantor Global Healthcare Conference
Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
GlobeNewswire Inc.
Jul 21, 2025 11:00 AM GMT
PRINCETON, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, July 31, 2025, at 8:30 a.m. ET to discuss financial results for t